“ú–{ˆã‰È‘åŠwˆãŠw‰ïŽGŽ Online Journal ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚ð”ò‚΂·
‘–ÚŽŸ > †–ÚŽŸ > Abstract ƒz[ƒ€‚Ö–ß‚é
Abstract

‘æ17Šª 2021”N10ŒŽ@‘æ4†

‘S•¶PDF (384K)

¡Ç—á•ñ

ƒlƒtƒ[ƒ[ÇŒóŒQÄ”­Žž‚É[•”Ö¬ŒŒðǂ𕹔­‚µ‚½1—á
“c•Ó@—YŽŸ˜Y, –öŒ´@„, ‹g“c@Œ\Žu, ”‹´@Žõ˜a, ˆÉ“¡@•Û•F
“ú–{ˆã‰È‘åŠw•t‘®•a‰@¬Ž™‰È

A Case of Venous Thrombosis at the Time of Recurrence of Nephrotic Syndrome
Yujiro Tanabe, Tsuyoshi Yanagihara, Keishi Yoshida, Toshikazu Itabashi and Yasuhiko Itoh
Departments of Pediatrics, Nippon Medical School

Nephrotic syndrome is known to cause hypercoagulation due to various factors. Steroid therapy is considered the main treatment for nephrotic syndrome. However, this can increase the risk of developing venous thromboembolism, prompting caution in its use. Here, we report a case of venous thromboembolism in a 13-year-old girl with acute renal failure. This developed during catheter insertion into the right internal jugular vein for hemodialysis. We initiated direct oral anticoagulant therapy. Ultrasound was used to monitor the jugular vein. Throughout the course of treatment, the venous thrombosis gradually disappeared. This study highlights the importance of considering prophylactic anticoagulant therapy in patients with nephrotic syndrome who have an increased risk of venous thromboembolism during central venous catheter placement.

“úˆã‘åˆã‰ïŽ 2021; 17(4), 182-185

Key words
nephrotic syndrome, venous thromboembolism, direct oral anticoagulant, acute renal failure

Correspondence to
Yujiro Tanabe, Departments of Pediatrics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113|8603, Japan
E-mailFy-tanabe@nms.ac.jp

Žó•tF2021”N5ŒŽ19“ú@Žó—F2021”N6ŒŽ10“ú

ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚Ö–ß‚é ‚±‚̃y[ƒW‚̃gƒbƒv‚Ö–ß‚é